“Why was I turned down?” is one of the hardest conversations in transplant hepatology — and one of the most misunderstood. Patients often assume a “no” is final. In most cases, it isn’t. It’s a “not yet,” tied to a specific, often reversible reason.
Understanding the real categories — permanent vs. temporary, medical vs. donor-related — changes how patients respond to a difficult evaluation outcome.
If you’re wondering whether you should be evaluated at all, start with am I a good candidate for a liver transplant.
The two categories that matter
Absolute contraindications — conditions where transplant surgery itself would very likely do more harm than the disease being treated, regardless of timing. Relative / reversible contraindications — conditions that currently make transplant unsafe or premature, but that can potentially be treated, stabilized, or resolved before reassessment. Most patients I see who are initially declined fall into the second category. That distinction is worth repeating to every patient who hears “no” for the first time.Absolute contraindications
- Active, uncontrolled extrahepatic malignancy (cancer outside the liver that has spread)
- Severe, irreversible cardiac or pulmonary disease that makes major surgery unsafe
- Ongoing, uncontrolled sepsis
- Advanced HCC with extensive vascular invasion or spread beyond transplant criteria
- Inability to comply with lifelong immunosuppression (severe, unaddressed psychiatric or cognitive impairment without a support structure)
Relative contraindications — the “not yet” category
This is where most real-world evaluations land, and where careful management can change the outcome entirely. Active alcohol or substance use. I don’t apply a fixed abstinence period as a hard rule — this is genuinely case-by-case. What I weigh: whether this is a first episode or a recurrent pattern of alcohol-related hepatitis, the strength of the patient’s social and psychological support system, and — critically — insight. A patient who understands why they’re here and what a relapse would cost them post-transplant is a different case from one who doesn’t, even if the liver numbers look identical. Duration of abstinence expected before listing follows the same case-by-case logic, not a fixed calendar rule. Active infection. A controlled, treated infection is not an automatic exclusion — carefully selected cases can proceed once infection is under control, rather than waiting for complete resolution in every instance. Poor nutritional status / sarcopenia. Often addressable with a pre-transplant optimization program rather than disqualifying on its own. Uncontrolled cardiac risk factors. Frequently manageable with cardiology optimization before reassessment. Advanced age alone. Age is just a number. I’ve evaluated physiologically fit patients well beyond the age most people assume is a cutoff — what matters is functional status, not the birth certificate. Psychosocial instability or lack of support system. Often addressable through counseling and building a support plan, not an automatic exclusion. When I see this on evaluation, I don’t treat it as a closed door — I sit down with the patient and family, name the gap plainly, and work out concretely who fills it: a family member taking responsibility for medication timing, a structured follow-up plan, a social worker brought in early. The goal is a real support plan on paper before relisting, not a vague reassurance. Case: recovery without transplant. A young male presented with a first episode of severe alcoholic hepatitis — a Maddrey discriminant function score above 80, meeting criteria for severe disease, and a clinical picture that looked transplant-bound on the surface. A sepsis screen came back negative. With steroid therapy and aggressive nutritional support, he recovered without needing transplantation. This is the case I point to when patients assume a severe presentation automatically means surgery — a first episode, in the right patient, with the right support, can resolve with medical management alone.Donor-side disqualification (LDLT-specific)
In living donor transplant, the donor can also be found unsuitable, independent of the recipient’s status:- Blood type incompatibility — not automatically disqualifying. ABO-incompatible (ABOI) transplant is an option in selected patient cohorts. In adult living-donor series with modern desensitization protocols (rituximab-based), reported 1-, 3-, and 5-year patient survival runs in the low-to-mid 70s–80s percent range, broadly comparable to ABO-compatible LDLT in the same cohorts — for example, one adult cohort reported 1-/3-/5-year survival of 81.7%/75.7%/71.0% for ABOI versus 81.0%/75.2%/71.5% for ABO-compatible recipients, with 3-year graft and patient survival of 89.2% and 92.3% respectively.
- Insufficient graft-to-recipient weight ratio
- Donor medical conditions that make major surgery unsafe for a healthy person
- Evidence of coercion or lack of true informed consent — donor evaluation includes independent psychological assessment specifically to screen for this
What happens after a “no”
Being declined at one point in time is not a permanent verdict for most relative contraindications. The typical path:- Identify the specific reversible factor
- Treat or optimize it
- Reassess at an interval matched to the clinical picture